Sanjay Kumar

Computational de novo discovery of novel mTOR inhibitors using recurrent neural networks and integrated in silico approaches including docking and DFT

A Recurrent Neural Network-based de novo drug design approach was employed to discover novel mTOR inhibitors, and S000031 emerged as the most promising candidate due to its superior binding affinity, structural novelty, and electronic characteristics.